These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 10479953)
1. Symptoms of patients suffering from somatoform disorders and ifenprodil. Masuda Y Psychosomatics; 1999; 40(5):449. PubMed ID: 10479953 [No Abstract] [Full Text] [Related]
2. [Cerebral circulatory improvers and metabolic activators]. Otomo E No To Shinkei; 1994 Mar; 46(3):239-44. PubMed ID: 8192938 [No Abstract] [Full Text] [Related]
3. [Treatment by medicine which improves cerebral circulation and metabolism]. Katsumata T; Katayama Y Nihon Rinsho; 2006 Nov; 64 Suppl 8():81-4. PubMed ID: 17469538 [No Abstract] [Full Text] [Related]
4. Pregabalin in patients with antidepressant treatment-resistant somatoform disorders: a case series. Harnack D; Scheel M; Mundt A; Kupsch A; Heinz A; Ströhle A J Clin Psychopharmacol; 2007 Oct; 27(5):537-9. PubMed ID: 17873703 [No Abstract] [Full Text] [Related]
5. Antidepressants and somatic symptoms: therapeutic actions are expanding beyond affective spectrum disorders to functional somatic syndromes. Stahl SM J Clin Psychiatry; 2003 Jul; 64(7):745-6. PubMed ID: 12934972 [TBL] [Abstract][Full Text] [Related]
6. [Rational selection of vasoactive drugs for the treatment of patients with vestibular dysfunction]. Boĭko NV Vestn Otorinolaringol; 1991; (5):42-7. PubMed ID: 1755185 [No Abstract] [Full Text] [Related]
7. [Pharmacological correction of Alzheimer's disease (review of the literature)]. Groppa SA Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):110-6. PubMed ID: 1686127 [No Abstract] [Full Text] [Related]
9. [Vasoactive combination treatment in cerebrovascular sclerosis]. Klein K Wien Med Wochenschr; 1973 Jan; 123(1):14-8. PubMed ID: 4405190 [No Abstract] [Full Text] [Related]
10. [Effect of a vasoactive agent on brain circulation]. Haragus S; Muresan IG; Schneider E Wien Med Wochenschr; 1972 Mar; 122(11):152-7. PubMed ID: 5047084 [No Abstract] [Full Text] [Related]
11. [Autonomic effect of grandaxin in the treatment of neurotic disorders in general somatic practice (lecture)]. Aleksandrovskiĭ IuA; Avedisova AS; Pavlova MS Ter Arkh; 1998; 70(10):76-8. PubMed ID: 9864811 [No Abstract] [Full Text] [Related]
12. [Preliminary results in the modifications of cerebral blood flow using xenon-133 during administration of ginkgo-biloba]. Agnoli A; Fiorani P; Pistolese GR Minerva Med; 1973 Nov; 64(79 Suppl):4166-73. PubMed ID: 4378392 [No Abstract] [Full Text] [Related]
13. [2: Patient with somatoform manifestations of depression. How to promote insight?]. Zacher A MMW Fortschr Med; 2003 Jun; 145(26):48-50. PubMed ID: 12916338 [No Abstract] [Full Text] [Related]
14. [Studies on the effect of a new coronary vessel dilating substance, carbochromen, on the blood circulation and metabolism of the brain]. Yamaoka S; Okada T; Kawamura M; Saito Y Med Welt; 1968 Mar; 12():764-70. PubMed ID: 5728935 [No Abstract] [Full Text] [Related]
15. A new approach to the assessment of the treatment effects of somatoform disorders. Rief W; Hiller W Psychosomatics; 2003; 44(6):492-8. PubMed ID: 14597684 [TBL] [Abstract][Full Text] [Related]